MF-094

Catalog No.E1098 Batch:E109801

Print

Technical Data

Formula

C30H37N3O4S
Molecular Weight 535.70 CAS No. 2241025-68-1
Solubility (25°C)* In vitro DMSO 100 mg/mL (186.67 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
2.5mg/ml Taking the 1 mL working solution as an example, add 50 μL of 50 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
Clear solution
5% DMSO 95% Corn oil
0.6mg/ml Taking the 1 mL working solution as an example, add 50 μL of 12 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description MF-094, a potent and selective USP30 inhibitor (IC50=0.12 μM), accelerates diabetic wound healing by inhibiting the NLRP3 inflammasome.
Targets
USP30 [1]
0.12 μM
In vitro

MF-094 restores viability and migration of AGE-treated HSF2 cells. MF-094 treatment decreases protein levels of NLRP3 and its downstream target caspase-1 p20.[2]
In vivo

MF-094 treatment facilitates wound healing in diabetic rats.[2]

Protocol (from reference)

Cell Assay:

[2]
  • Cell lines

    HSF2 human skin fibroblasts

  • Concentrations

    100 nM

  • Incubation Time

    24 h

  • Method

    HSF2 cells are treated with USP30 inhibitor MF-094 (100 nM) or transduced with shUSP30 lentivirus vector for 24 h, following 200 μg/ml AGE treatment for 24 h. After treatment, HSF2 cells (5 × 105 cells/well) are plated in 96- well plates and cultured for 0, 12, 24, and 48 h. Then, 10 ml CCK-8 solution is added to cells for cell viability assay. The protein levels of NLRP3 and P20 are determined by Western blot.
Animal Study:

[2]
  • Animal Models

    Streptozotocin (STZ) induced diabetic rats

  • Dosages

    50 mg/kg

  • Administration

    i.p.

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.